The DOI matches its Crossref record, with a small difference in title or year; 263 of the 263 references it cites were found in a registry or an index.
Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association
Open accessAbstract
Cardiovascular disease risk factor control as primary prevention in patients with type 2 diabetes mellitus has changed substantially in the past few years. The purpose of this scientific statement is to review the current literature and key clinical trials pertaining to blood pressure and blood glucose control, cholesterol management, aspirin therapy, and lifestyle modification. We present a synthesis of the recent literature, new guidelines, and clinical targets, including screening for kidney and subclinical cardiovascular disease for the contemporary management of patients with type 2 diabetes mellitus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As such, while all patients with T2DM and CAD certainly benefit from a blood pressure of <140/90 mm Hg,5,63–66,76”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [63]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For people who already have diabetes, lifestyle modification and pharmacological treatment, as well as blood pressure and cholesterol control, can delay progression to complications and reduce mortality, or even help with remission, especially if started early.1,2,58–62”
From Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants (2024) · cites this paper as [59]
Experimental — accuracy not yet measuredIn the citing paper
“Epidemiological studies have shown that high levels of LDL-C and non-HDL-C and low levels of HDL-C are associated with an increased risk of CV events and mortality in patients with and without diabetes.246”
From 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. (2023) · cites this paper as [246]
In the citing paper
“The most common causes of death in patients with T2DM and CKD are atherosclerotic cardiovascular disease (ASCVD) and heart failure (HF) (6,7).”
From SGLT2 inhibition for CKD and cardiovascular disease in type 2 diabetes: report of a scientific workshop sponsored by the National Kidney Foundation (2021) · cites this paper as [7]
In the citing paper
“The presence of hypertension in patients with T2DM significantly increases the risk of myocardial infarction, stroke, and all-cause mortality.63,64”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [63]
In the citing paper
“The prevalence of hypertension in patients with T2DM is ≈2-fold greater than in the general population, with the vast majority of patients with T2DM (70%–80%) having concomitant hypertension.63”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [63]
In the citing paper
“Early interventional randomized trials showed benefit of aggressive blood pressure reduction in reducing the increased risk of both macrovascular and microvascular events in patients with T2DM.63”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [63]
In the citing paper
“Epidemiological observations have demonstrated that there is a progressive increase in the risk of macrovascular and microvascular events with increasing levels of systolic blood pressure starting at 115 mm Hg.63–65”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [63]
In the citing paper
“Instead, evidence to support lifestyle and health behavior management for T2DM and stable CAD has been extrapolated from primary prevention trials and from subgroups of participants with T2DM from studies focusing on the secondary prevention of CAD.63,136”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Items 201–263 of 263
Weight gain as an adverse effect of some commonly prescribed drugs: a systematic review
Leslie, W. S., Hankey, C. R., & Lean, M. E. J. (2007) · QJM · doi:10.1093/qjmed/hcm044 · Cited by 173
Group1a*, M. S. O. A. A. D. (. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(96)00699-6 · Cited by 170
Maintaining large weight losses: The role of behavioral and psychological factors.
Wing, R. R., Papandonatos, G., Fava, J. L., Gorin, A. A., Phelan, S., McCaffery, J., & Tate, D. F. (2008) · Journal of Consulting and Clinical Psychology · doi:10.1037/a0014159 · Cited by 166
Metabolic Syndrome, Diabetes, and Incidence and Progression of Coronary Calcium
Wong, N. D., Nelson, J. C., Granston, T., Bertoni, A. G., Blumenthal, R. S., Carr, J. J., Guerci, A. D., Jacobs, D. R., Kronmal, R. A., Liu, K., et al. (2012) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2011.12.015 · Cited by 163
Self-citationSevere Hypoglycemia Predicts Mortality in Diabetes
Cryer, P. E. (2012) · Diabetes Care · doi:10.2337/dc12-0749 · Cited by 163
The Impact of Frequent and Unrecognized Hypoglycemia on Mortality in the ACCORD Study
Seaquist, E. R., Miller, M. E., Bonds, D. E., Feinglos, M. N., Goff, D. C., PETERSON, K. A., Senior, P. A., & for the ACCORD Investigators (2011) · Diabetes Care · doi:10.2337/dc11-0996 · Cited by 161
Scholte, A. J. H. A., Schuijf, J. D., Kharagjitsingh, A. V., Jukema, J. W., Pundziūtė, G., van der Wall, E. E., & Bax, J. J. (2007) · Heart · doi:10.1136/hrt.2007.121921 · Cited by 160
Use of HbA1c in Predicting Progression to Diabetes in French Men and Women
Droumaguet, C., Balkau, B., Simon, D., Caces, E., Tichet, J., Charles, M. A., Eschwege, E., & the DESIR Study Group (2006) · Diabetes Care · doi:10.2337/dc05-2525 · Cited by 159
Cheng, Y. J., Gregg, E. W., Geiss, L. S., Imperatore, G., Williams, D. E., Zhang, X., Albright, A. L., Cowie, C. C., Klein, R., & Saaddine, J. B. (2009) · Diabetes Care · doi:10.2337/dc09-0440 · Cited by 157
Performance of A1C for the Classification and Prediction of Diabetes
Selvin, E., Steffes, M. W., Gregg, E. W., Brancati, F. L., & Coresh, J. (2010) · Diabetes Care · doi:10.2337/dc10-1235 · Cited by 154
Self-citationDuckworth, W. C., Abraira, C., Moritz, T. E., Davis, S. N., Emanuele, N., Goldman, S., Hayward, R., Huang, G. D., Marks, J. B., Reaven, P. D., et al. (2011) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2011.10.003 · Cited by 152
Aspirin for primary prevention of cardiovascular events in patients with diabetes: A meta-analysis
Zhang, C., Sun, A., Zhang, P., Wu, C., Zhang, S., Fu, M., Wang, K., Zou, Y., & Ge, J. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.09.029 · Cited by 150
Berger, J. S., Lala, A., Krantz, M. J., Baker, G. S., & Hiatt, W. R. (2011) · American Heart Journal · doi:10.1016/j.ahj.2011.04.006 · Cited by 145
Hoff, J. A., Quinn, L., Sevrukov, A., Lipton, R. B., Daviglus, M. L., Garside, D. B., Ajmere, N. K., Gandhi, S., & Kondos, G. T. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02975-3 · Cited by 144
Self-citationEffects of Bilio-Pancreatic Diversion on Diabetic Complications
Iaconelli, A., Panunzi, S., Gaetano, A. D., Manco, M., Guidone, C., Leccesi, L., Gniuli, D., Nanni, G., Castagneto, M., Ghirlanda, G., et al. (2011) · Diabetes Care · doi:10.2337/dc10-1761 · Cited by 141
Selvin, E., Yang, N., Steffes, M. W., Bash, L. D., Klein, R., Wong, T. Y., Astor, B. C., Sharrett, A. R., Brancati, F. L., & Coresh, J. (2010) · Diabetes · doi:10.2337/db10-1198 · Cited by 137
Self-citationLow glycaemic index diets for coronary heart disease
Kelly, S. A., Frost, G., Whittaker, V., & Summerbell, C. D. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004467.pub2 · Cited by 122
Medical Therapy for the Patient With Obesity
Bray, G. A., & Ryan, D. H. (2012) · Circulation · doi:10.1161/circulationaha.111.026567 · Cited by 120
Self-citationStanger, O., Herrmann, W., Pietrzik, K. F., Fowler, B., Geisel, J., Dierkes, J., & Weger, M. (2004) · Zeitschrift für Kardiologie · doi:10.1007/s00392-004-0075-3 · Cited by 119
Prognostic Significance of Silent Myocardial Infarction in Newly Diagnosed Type 2 Diabetes Mellitus
Davis, T. M. E., Coleman, R. L., & Holman, R. R. (2013) · Circulation · doi:10.1161/circulationaha.112.000908 · Cited by 115
Anand, S., Dagenais, G. R., Mohan, V., Díaz, R., Probstfield, J. L., Freeman, R. V., Shaw, J. E., Lanas, F. T., Avezum, Á., Budaj, A., et al. (2011) · European Journal of Preventive Cardiology · doi:10.1177/1741826711409327 · Cited by 115
the DYNAMIT investigators, Lièvre, M. M., Moulin, P., Thivolet, C. H., Rodier, M., Rigalleau, V., Penfornis, A., Pradignac, A., & Ovize, M. (2011) · Trials · doi:10.1186/1745-6215-12-23 · Cited by 112
Lacher, D. A., Hughes, J. P., & Carroll, M. D. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2004.039354 · Cited by 112
"STOP regain": Are there negative effects of daily weighing?
Wing, R. R., Tate, D. F., Gorin, A. A., Raynor, H. A., Fava, J. L., & Machan, J. T. (2007) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.75.4.652 · Cited by 110
Serious Cardiovascular Outcomes in Diabetes
Yakubovich, N., & Gerstein, H. C. (2011) · Circulation · doi:10.1161/circulationaha.110.948489 · Cited by 104
Aspirin for the Primary Prevention of Cardiovascular Events
Calvin, A. D., Aggarwal, N. R., Murad, M. H., Shi, Q., Elamin, M. B., Geske, J. B., Fernández-Balsells, M., Albuquerque, F. N., Lampropulos, J. F., Erwin, P. J., et al. (2009) · Diabetes Care · doi:10.2337/dc09-1297 · Cited by 98
Scheidt‐Nave, C., Barrett-Connor, E. L., & WINGARD, D. L. (1990) · Circulation · doi:10.1161/01.cir.81.3.899 · Cited by 97
Susceptibility of LDL and its subfractions to glycation
Soran, H., & Durrington, P. N. (2011) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328348a43f · Cited by 91
Rissanen, A., Lean, M. E. J., Rössner, S., Segal, K. R., & Sjöström, L. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.0802165 · Cited by 88
Tracking of glycated hemoglobin in the original cohort of the framingham heart study
Meigs, J. B., Nathan, D. M., Cupples, L. A., Wilson, P. W. F., & Singer, D. E. (1996) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(95)00513-7 · Cited by 84
Navaneethan, S. D., Kelly, K. R., Sabbagh, F. H. E., Schauer, P. R., Kirwan, J. P., & Kashyap, S. R. (2009) · Obesity Surgery · doi:10.1007/s11695-009-0026-1 · Cited by 82
Self-citationAspirin for the Primary Prevention of Cardiovascular Disease in Women
Pignone, M. P. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.3.290 · Cited by 76
Self-citationCoronary Calcium Score and Prediction of All-Cause Mortality in Diabetes
Agarwal, S., Morgan, T. M., Herrington, D. M., Xu, J., Cox, A. J., Freedman, B. I., Carr, J. J., & Bowden, D. W. (2011) · Diabetes Care · doi:10.2337/dc11-0008 · Cited by 75
Clinical potential of sodium-glucose cotransporter 2 inhibitors in the management of type 2 diabetes
Babu, A. R., Kim, S., & Babu, A. R. (2012) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s22545 · Cited by 71
Surgical Management of Obesity and the Relationship to Cardiovascular Disease
Vest, A. R., Heneghan, H., Schauer, P. R., & Young, J. B. (2013) · Circulation · doi:10.1161/circulationaha.112.103275 · Cited by 66
Self-citationBybee, K. A., Lee, J., Markiewicz, R., Longmore, R. B., McGhie, A. I., O’Keefe, J. H., Hsu, B., Kennedy, K. F., Thompson, R. C., & Bateman, T. M. (2009) · Journal of Nuclear Cardiology · doi:10.1007/s12350-009-9159-9 · Cited by 65
Prediction of response to sibutramine therapy in obese non‐diabetic and diabetic patients
Finer, N., Ryan, D. H., Renz, C. L., & Hewkin, A. C. (2005) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2005.00481.x · Cited by 62
Gerstein, H. C., Islam, S., Anand, S. S., Almahmeed, W. A., Damasceno, A. A. M., Dans, A., Lang, C. C., Luna, M. A., McQueen, M., Rangarajan, S., et al. (2010) · Diabetologia · doi:10.1007/s00125-010-1871-0 · Cited by 59
Cushing Syndrome Secondary to A Thymic Carcinoid Tumor Due to Multiple Endocrine Neoplasia Type 1
Ghazi, A. A., Dezfooli, A. A., Mohamadi, F., Yousefi, S. V., Amirbaigloo, A., Ghazi, S. M., Pourafkari, M., Berney, D. M., Ellard, S., & Grossman, A. B. (2011) · Endocrine Practice · doi:10.4158/ep11038.cr · Cited by 59
Balducci, S., Zanuso, S., Massarini, M., Corigliano, G., Nicolucci, A., Missori, S., Cavallo, S., Cardelli, P., Alessi, E., Pugliese, G., et al. (2008) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2007.07.006 · Cited by 59
Diabetes Mellitus and Trends in Hospital Survival After Myocardial Infarction, 1994 to 2006
Gore, M. O., Patel, M. J., Kosiborod, M., Parsons, L. S., Khera, A., de Lemos, J. A., Rogers, W. J., Peterson, E. D., Canto, J. G., McGuire, D. K., et al. (2012) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.112.965491 · Cited by 47
Self-citationScholte, A. J. H. A., Bax, J. J., & Wackers, F. J. T. (2006) · Journal of Nuclear Cardiology · doi:10.1016/j.nuclcard.2005.11.002 · Cited by 46
The Parathyroid Glands: What The Endocrine Surgeon Should Know
Perrier, N. D. (2011) · Endocrine Practice · doi:10.4158/ep11007.co · Cited by 45
A Guide to Obesity and the Metabolic Syndrome
Bray, G. A. (2011) · CRC Press eBooks · doi:10.1201/b10790 · Cited by 45
Self-citationDo Lifestyle Changes Reduce Serious Outcomes in Diabetes?
Gerstein, H. C. (2013) · New England Journal of Medicine · doi:10.1056/nejme1306987 · Cited by 45
Younis, N., Williams, S. D., Ammori, B. J., & Soran, H. (2010) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656561003792538 · Cited by 43
Pharmacologic Treatment Options for Obesity: What Is Old Is New Again
Ryan, D. H., & Bray, G. A. (2013) · Current Hypertension Reports · doi:10.1007/s11906-013-0343-6 · Cited by 42
Self-citationSimpson, S. H., Gamble, J., Mereu, L., & Chambers, T. (2011) · Journal of General Internal Medicine · doi:10.1007/s11606-011-1757-y · Cited by 42
New Diabetes Diagnostic Threshold of Hemoglobin A1c and the 3-Year Incidence of Retinopathy
Tsugawa, Y., Takahashi, O., Meigs, J. B., Davis, R. B., Imamura, F., Fukui, T., Taylor, W. C., & Wee, C. C. (2012) · Diabetes · doi:10.2337/db12-0103 · Cited by 41
Rubin, R. R., Peyrot, M. F., Gaussoin, S. A., Espeland, M. A., Williamson, D. A., Faulconbridge, L. F., Wadden, T. A., Ewing, L. J., Safford, M. M., Evans-Hudnall, G. L., et al. (2013) · Diabetes Care · doi:10.2337/dc12-1871 · Cited by 40
DEEDWANIA, P. C. (2005) · Cardiology Clinics · doi:10.1016/j.ccl.2004.06.006 · Cited by 39
Self-citationAlogliptin after acute coronary syndrome in patients with type 2 diabetes
Examine Investigators (2014) · Aston Publications Explorer (Aston University) · Cited by 36
Treatment of the Obese Patient in Primary Care: Targeting and Meeting Goals and Expectations
Bray, G. A., Look, M., & Ryan, D. H. (2013) · Postgraduate Medicine · doi:10.3810/pgm.2013.09.2692 · Cited by 34
Self-citationBlood Pressure Control in Diabetes Mellitus: Is Lower Always Better, and How Low Should it Go?
Deedwania, P. C. (2011) · Circulation · doi:10.1161/circulationaha.111.033704 · Cited by 29
Self-citationScreening for Coronary Artery Disease in Type 2 Diabetes
Upchurch, C. T., & Barrett, E. J. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2122 · Cited by 26
Low glycaemic index diets for coronary heart disease
Kelly, S. A., Summerbell, C., Ashton, V. J., & Frost, G. S. (2003) · doi:10.1002/14651858.cd004467 · Cited by 22
Koška, J., Saremi, A., Bahn, G., Yamashita, S., Reaven, P. D., & for the Veterans Affairs Diabetes Trial Investigators (2013) · Diabetes Care · doi:10.2337/dc12-2082 · Cited by 21
Joffe, H. V., Parks, M. H., & Temple, R. (2010) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-010-9130-8 · Cited by 21
Chronic Kidney Disease Stages 1–3
Ha, F., Ishani, A., Taylor, B. C., Nl, G., MacDonald, R. H., Rossini, D., Sadiq, S., Lankireddy, S., Kane, R. L., & Tj, W. (2012) · Europe PMC (PubMed Central) · Cited by 18
A Guide to Obesity and the Metabolic Syndrome: Origins and Treatment
Bray, G. A. (2011) · Cited by 18
Self-citationNutrients and cardiovascular disease: no easy answers – editorial review
Lichtenstein, A. H. (2005) · Current Opinion in Lipidology · doi:10.1097/00041433-200502000-00002 · Cited by 11
Lifestyle intervention strategies to prevent and control type 2 diabetes
Otto, A. D., Garcia, D. O., & Jakicic, J. M. (2008) · Current Diabetes Reports · doi:10.1007/s11892-008-0070-6 · Cited by 9
Kondola, S., Davis, W. A., Dembo, L. G., & Davis, T. M. E. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.06.016 · Cited by 5
Research works printed but not linked: 2
- 10.1161/circ.100.10.1132 · DOI
- Levin A, Stevens PE, Bilous RW, Coresh J, De Francisco ALM, de Jong PE, Griffith KE, Hemmelgarn BR, Iseki K, Lamb EJ, Levey AS, Riella MC, Shlipak MG, Wang H, White CT, Winearls CG. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group: KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3:1–150.
Cited by
Sorted by citations
Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association
Benjamin, E. J., Blaha, M. J., Chiuve, S. E., Cushman, M., Das, S. R., Deo, R., de Ferranti, S. D., Floyd, J., Fornage, M., Gillespie, C., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000485 · Cited by 12,591
Heart disease and stroke statistics-2018 update: a report from the american heart association
Benjamin, E. J., Virani, S. S., Callaway, C. W., Chamberlain, A. M., Chang, A. R., Cheng, S., Chiuve, S. E., Cushman, M., Delling, F. N., Deo, R., et al. (2018) · Circulation · doi:10.1161/cir.0000000000000558 · Cited by 7,146
Heart Disease and Stroke Statistics—2016 Update: A Report From the American Heart Association
Mozaffarian, D., Benjamin, E. J., Go, A. S., Arnett, D. K., Blaha, M. J., Cushman, M., Das, S. R., de Ferranti, S., Després, J.-P., Fullerton, H. J., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000350 · Cited by 6,596
Zhou, B., Lu, Y., Hajifathalian, K., Bentham, J., Di Cesare, M., Danaei, G., Bixby, H., Cowan, M., Ali, M., Taddei, C., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00618-8 · Cited by 4,311
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
Pfeffer, M. A., Claggett, B., Diaz, R., Dickstein, K., Gerstein, H. C., Køber, L. V., Lawson, F. C., Ping, L., Wei, X., Lewis, E. F., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1509225 · Cited by 2,409
Metadata
- Authors
- Fox, C. S., Golden, S. H., Anderson, C., Bray, G. A., Burke, L. E., de Boer, I. H., Deedwania, P., Eckel, R. H., Ershow, A. G., Fradkin, J., Inzucchi, S. E., Kosiborod, M., Nelson, R. G., Patel, M. J., Pignone, M., Quinn, L., Schauer, P. R., Selvin, E., & Vafiadis, D. K.
- Affiliations
- National Heart, Lung, and Blood Institute (US)
- Johns Hopkins University (US)
- University of California San Diego (US)
- Pennington Biomedical Research Center (US)
- University of Pittsburgh (US)
- University of California, San Francisco (US)
- Office of Dietary Supplements (US)
- National Institutes of Health (US)
- Yale University (US)
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- University of Illinois Chicago (US)
- Cleveland Clinic (US)
- American Heart Association (US)
- ORCID
- Venue
- Circulation
- Published
- 2015-08-25
- Volume
- 132
- Issue
- 8
- Pages
- 691-718
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- PMC
- PMC9728095
- OpenAlex
- W2172043580
- Cited by
- 386
- References
- 262
- Citations by year
- 2026: 16 · 2025: 8 · 2024: 18 · 2023: 18 · 2022: 35 · 2021: 40 · 2020: 45 · 2019: 41 · 2018: 55 · 2017: 61 · 2016: 42 · 2015: 7
- FWCI
- 47.74
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (ZIADK069062, P30DK079637)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
- Keywords
- type 2 diabetes, cardiovascular disease prevention, primary prevention, blood pressure control, glycemic control, cholesterol management, aspirin therapy, lifestyle modification, kidney disease screening, subclinical cardiovascular disease, clinical guidelines
- MeSH terms
- American Heart Association, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Humans, Primary Prevention, Risk Factors, United States, Randomized Controlled Trials as Topic, Practice Guidelines as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
